Anteris Technologies Prepares for Key Meetings
Company Announcements

Anteris Technologies Prepares for Key Meetings

Anteris Technologies (AU:AVR) has released an update.

Anteris Technologies Ltd has dispatched the Scheme Booklet to its shareholders and optionholders, detailing instructions for the upcoming Extraordinary General Meeting and Scheme Meetings scheduled for October 4, 2024. The materials, including an Independent Expert’s Report, are available on the company’s website, and stakeholders are encouraged to participate and vote in person or through provided proxy forms. Anteris is a structural heart company with a focus on developing medical devices, including a bioengineered transcatheter heart valve aimed at addressing aortic stenosis.

For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskAnteris Technologies Issues New Convertible Notes
TipRanks Australian Auto-Generated NewsdeskAnteris Technologies Announces New Securities Issue
TipRanks Australian Auto-Generated NewsdeskAnteris Technologies Sees Shift in Shareholder Voting Power
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App